ABCA1 and myeloid sarcoma: Meanwhile, Kan et al. recently reported that administration of FTY720 was associated with a specific increase in HDL in MS patients, suggesting that the anti-atherosclerotic effect of FTY720 may be mediated by HDL and ABCA1 [19].